Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04550442
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2020-09-09
Brief Title:
Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Sponsor:
Organization:
MD Anderson Cancer Center